W P Vaughan
Overview
Explore the profile of W P Vaughan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
493
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elwood T, Waalkes T, Vaughan W
Int Q Community Health Educ
. 2010 Sep;
2(1):35-49.
PMID: 20841086
The Johns Hopkins Oncology Center, one of the first of the nation's twenty-one Comprehensive Cancer Centers, established a cancer control program to mobilize resources to improve patient care and prevent...
2.
Nieto Y, Vaughan W
Bone Marrow Transplant
. 2003 Dec;
33(3):259-69.
PMID: 14647243
There is considerable variation in the severity of preparative regimen-related toxicity (RRT) in hematopoietic stem-cell transplantation (HSCT). This variation has been recognized to be due, in part, to the wide...
3.
4.
Adler B, Salzman D, Carabasi M, Vaughan W, Reddy V, Prchal J
Blood
. 2001 May;
97(10):3313-4.
PMID: 11368061
No abstract available.
5.
Andersson B, Madden T, Tran H, Hu W, Blume K, Chow D, et al.
Biol Blood Marrow Transplant
. 2000 Nov;
6(5A):548-54.
PMID: 11071260
The unpredictable intestinal absorption and erratic bioavailability of oral busulfan (Bu) has limited the drug's use in high-dose pretransplantation conditioning therapy. To standardize drug delivery, we solubilized Bu for parenteral...
6.
Lucas K, Sun Q, Burton R, Tilden A, Vaughan W, Carabasi M, et al.
Hum Gene Ther
. 2000 Jul;
11(10):1453-63.
PMID: 10910142
Epstein-Barr virus (EBV)-induced lymphoproliferative disease and cytomegalovirus (CMV) infection are major causes of morbidity and mortality in individuals with compromised cellular immunity. Although anti-viral pharmacological agents exist, severe side effects...
7.
Rowlings P, Williams S, Antman K, Fields K, Fay J, Reed E, et al.
JAMA
. 1999 Oct;
282(14):1335-43.
PMID: 10527180
Context: Women with breast cancer are the most frequent recipients of high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (autotransplants) in North America. Despite widespread use, controversy exists about...
8.
Vaughan W, SILVER S, Beatty P, Tallman M
Oncology (Williston Park)
. 1999 Feb;
12(11A):390-2.
PMID: 10028522
A newly formed National Comprehensive Cancer Network (NCCN) panel on bone marrow transplantation has the task of ensuring the incorporation of allogeneic and autologous transplantation into all disease guidelines where...
9.
Edwards M, Gamel J, Vaughan W, Wrightson W
J Clin Oncol
. 1998 Aug;
16(8):2693-9.
PMID: 9704719
Purpose: Breast cancer has a poorer prognosis among black women than among white women. This review was conducted to determine whether this disparity reflects the direct impact of race on...
10.
Mann S, Joshi S, Crouse D, Armitage J, Kessinger A, Weisenburger D, et al.
Breast Cancer Res Treat
. 1997 Jun;
44(2):115-21.
PMID: 9232270
The maintenance of hematopoietic progenitor cells as assayed in the mixed colony (CFU-GEMM) assay in human long-term bone marrow cultures was compared between normal allogeneic marrow transplantation donor collections and...